Evidence map›Paper›PMID 42550950›Full record

ArticleJMIR AI2026

Benchmarking AI-Powered Translation of the EQ-5D-5L Patient-Reported Outcome Measure Using Automated Metrics: Comparative Evaluation Study.

Himanshu Vashisht, Tomás Ward, Willie Muehlhausen

Abstract read
In one paragraph

Article in JMIR AI, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Himanshu VashishtSchool of Computing, Dublin City University, Collins Ave Ext, Whitehall, Dublin, Ireland, 353 899586131.ORCID http://orcid.org/0000-0002-2726-946X
Tomás WardSchool of Computing, Dublin City University, Collins Ave Ext, Whitehall, Dublin, Ireland, 353 899586131.ORCID http://orcid.org/0000-0002-6173-6607
Willie MuehlhausenRinn Artificial Intelligence, Dublin City University, Dublin, Ireland.ORCID http://orcid.org/0000-0001-9198-1622

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Patient-reported outcome measures (PROMs) are central to multinational clinical research, but high-quality translation and linguistic validation remain resource-intensive. AI-powered translation may accelerate this process, but its performance relative to validated human PROM translations requires systematic evaluation. Objective: This benchmarking study evaluated the quality and comparability of 4 AI-powered translation services for the EuroQol 5-dimension 5-level (EQ-5D-5L) across 5 target languages, using official, linguistically validated human translations as the reference standard (gold standard). Methods: The 43 text segments of the EQ-5D-5L were translated from English into Danish, Dutch, French, German, and Spanish using Google Translate, GPT-4.1, Amazon Translate, and DeepL. GPT-4.1 was evaluated with a structured medical-translator prompt, whereas Google Translate, Amazon Translate, and DeepL were evaluated using standard unprompted application programming interfaces without domain-specific glossary constraints. Outputs were benchmarked against official, validated human translations using 4 automated metrics: BLEU (bilingual evaluation understudy), METEOR (metric for evaluation of translation with explicit ordering), COMET (cross-lingual optimized metric for evaluation of translation), and BLEURT (bilingual evaluation understudy with representations from transformers). Friedman tests were used to assess overall between-service differences within each metric-language combination. When the Friedman test was significant, paired Wilcoxon signed-rank post hoc tests with Holm-Bonferroni correction were conducted. Descriptive summaries, score distributions, and sentence-level hotspot analyses were used to evaluate semantic similarity patterns and identify localized low-scoring deviations. Results: Friedman tests assessed whether the AI services differed in performance, whereas descriptive summaries and visualizations were used to determine whether scores clustered in ranges consistent with strong semantic similarity to the gold standard. Friedman tests identified statistically significant between-service differences in 11 of the 20 (55%; P<.05) metric-language combinations. Subsequent paired Wilcoxon signed-rank post hoc tests with Holm-Bonferroni correction identified 11 significant pairwise differences, with adjusted P values ranging from <.001 to .049. Most of these differences were detected by surface-overlap metrics (10/11 for BLEU or METEOR), whereas only 1 of 11 was detected by a semantic metric (BLEURT), suggesting that many between-service differences were stylistic rather than meaning-altering. Descriptive and visual analyses further showed that semantic similarity was generally high across services, while low-scoring deviations clustered in specific linguistic hotspots, particularly domain headers, abstract health concepts, and short, context-dependent interface strings. Conclusions: Among the evaluated high-resource European languages, AI translation services showed high semantic similarity to the validated human translations, although localized conceptual deviations persisted. These findings suggest that AI can support the generation of translations for PROM workflows in these languages; however, expert human review may still be required to confirm conceptual equivalence. The practical relevance of isolated header differences could not be assessed in the present study, whereas abstract health concepts and other clinically sensitive phrasing should be evaluated in further research.

Indexed as

clinical researchelectronic clinical outcome assessmentEQ-5D-5Llinguistic validationmachine translationmultilingual studiespatient-reported outcomestranslation quality

Identifiers

PMID42550950
PMCPMC13436651

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.